This is important because the expression of endothelin (ET)-1, a vasoactive peptide primarily produced in endothelial, vascular smooth muscle, and epithelial cells that have been demonstrated significantly increased in numerous human malignancies including breast cancer. This evidence concerns the gene EDN1 and breast carcinoma.